These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29203302)

  • 1. Immunomodulatory effects of a rationally designed peptide mimetic of human IFNβ in EAE model of multiple sclerosis.
    Poorebrahim M; Asghari M; Abazari MF; Askari H; Sadeghi S; Taheri-Kafrani A; Nasr-Esfahani MH; Ghoraeian P; Aleagha MN; Arab SS; Kennedy D; Montaseri A; Mehranfar M; Sanadgol N
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():49-61. PubMed ID: 29203302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.
    Pacini G; Ieronymaki M; Nuti F; Sabatino G; Larregola M; Aharoni R; Papini AM; Rovero P
    J Pept Sci; 2016 Jan; 22(1):52-8. PubMed ID: 26663200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant soluble IFN receptor (sIFNAR2) exhibits intrinsic therapeutic efficacy in a murine model of Multiple Sclerosis.
    Suardíaz M; Clemente D; Marin-Bañasco C; Orpez T; Hurtado-Guerrero I; Pavía J; Pinto-Medel MJ; De Castro F; Leyva L; Fernández O; Oliver B
    Neuropharmacology; 2016 Nov; 110(Pt A):480-492. PubMed ID: 27452720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis.
    Yu M; Nishiyama A; Trapp BD; Tuohy VK
    J Neuroimmunol; 1996 Jan; 64(1):91-100. PubMed ID: 8598395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune Encephalomyelitis.
    Rajendran R; Rajendran V; Gupta L; Shirvanchi K; Schunin D; Karnati S; Giraldo-Velásquez M; Berghoff M
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. St. John's wort and its component hyperforin alleviate experimental autoimmune encephalomyelitis through expansion of regulatory T-cells.
    Nosratabadi R; Rastin M; Sankian M; Haghmorad D; Tabasi N; Zamani S; Aghaee A; Salehipour Z; Mahmoudi M
    J Immunotoxicol; 2016 May; 13(3):364-74. PubMed ID: 26634391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation.
    Reick C; Ellrichmann G; Thöne J; Scannevin RH; Saft C; Linker RA; Gold R
    Exp Neurol; 2014 Jul; 257():50-6. PubMed ID: 24731948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis.
    Fontes LB; Dos Santos Dias D; de Carvalho LS; Mesquita HL; da Silva Reis L; Dias AT; Da Silva Filho AA; do Amaral Corrêa JO
    J Pharm Pharmacol; 2014 Jun; 66(6):886-94. PubMed ID: 24447171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.
    Castro SB; Junior CO; Alves CC; Dias AT; Alves LL; Mazzoccoli L; Mesquita FP; Figueiredo NS; Juliano MA; Castañon MC; Gameiro J; Almeida MV; Teixeira HC; Ferreira AP
    Int Immunopharmacol; 2012 Feb; 12(2):465-70. PubMed ID: 22245971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active Induction of Experimental Autoimmune Encephalomyelitis (EAE) with MOG
    Giralt M; Molinero A; Hidalgo J
    Methods Mol Biol; 2018; 1791():227-232. PubMed ID: 30006713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
    Hu X; Qin X
    Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental Autoimmune Encephalomyelitis (EAE) Model of Cynomolgus Macaques Induced by Recombinant Human MOG1-125 (rhMOG1-125) Protein and MOG34-56 Peptide.
    Peng Z; Zhang L; Wang H; He X; Peng X; Zhang Q; Liu H; Rao J; Wang H; Wu J; Sun Y
    Protein Pept Lett; 2018 Feb; 24(12):1166-1178. PubMed ID: 29141529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity.
    Kocur M; Schneider R; Pulm AK; Bauer J; Kropp S; Gliem M; Ingwersen J; Goebels N; Alferink J; Prozorovski T; Aktas O; Scheu S
    Acta Neuropathol Commun; 2015 Apr; 3():20. PubMed ID: 25853624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.
    Bravo B; Gallego MI; Flores AI; Bornstein R; Puente-Bedia A; Hernández J; de la Torre P; García-Zaragoza E; Perez-Tavarez R; Grande J; Ballester A; Ballester S
    Stem Cell Res Ther; 2016 Mar; 7():43. PubMed ID: 26987803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis.
    Khorooshi R; Mørch MT; Holm TH; Berg CT; Dieu RT; Dræby D; Issazadeh-Navikas S; Weiss S; Lienenklaus S; Owens T
    Acta Neuropathol; 2015 Jul; 130(1):107-18. PubMed ID: 25869642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis.
    Trubiani O; Giacoppo S; Ballerini P; Diomede F; Piattelli A; Bramanti P; Mazzon E
    Stem Cell Res Ther; 2016 Jan; 7():1. PubMed ID: 26729060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT; Khorooshi R; Owens T
    Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis.
    Cappellano G; Woldetsadik AD; Orilieri E; Shivakumar Y; Rizzi M; Carniato F; Gigliotti CL; Boggio E; Clemente N; Comi C; Dianzani C; Boldorini R; Chiocchetti A; Renò F; Dianzani U
    Vaccine; 2014 Sep; 32(43):5681-9. PubMed ID: 25149432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
    Kassis I; Petrou P; Halimi M; Karussis D
    Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose-derived mesenchymal stem cells modulate the immune response in chronic experimental autoimmune encephalomyelitis model.
    Shalaby SM; Sabbah NA; Saber T; Abdel Hamid RA
    IUBMB Life; 2016 Feb; 68(2):106-15. PubMed ID: 26757144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.